Radiation is often given for DCIS, after lumpectomy. But that carries toxicity and risk, which is one of the reasons that some women choose, and some doctors recommend, mastectomy.

As doctors seek better understanding of DCIS, clinical trial focusing on surveillance enrolls affected breast cancer patients.

Lumpectomy plus radiation is associated with a small but statistically significant reduced risk for breast cancer-related death compared to the other major options for ductal carcinoma in situ (DCIS).

RTOG 9804 (and subsequently NRG/RTOG 9804) evaluated the impact of post-lumpectomy RT in women with good-risk DCIS. The study included 636 patients enrolled from 1999 to 2006, randomized to ...

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS. Journal of the National Cancer Institute , 2011 ...

A key finding is that a low Oncotype DX DCIS Score™ conferred a low chance of recurrent disease in the affected breast – around 12.7 percent – after lumpectomy alone, with a median follow-up ...

The standard of care for treating DCIS has been doing a lumpectomy or a mastectomy and sometimes radiation. “It’s potentially over-treating thousands of women who have a very, ...

A lumpectomy is usually given to people with early-stage breast cancers, including:. stage 1 breast cancer; stage 2 breast cancer; ductal carcinoma in situ (DCIS) The procedure is also sometimes ...

April 29 2010 — New research suggests that it might be possible to identify which women with ductal carcinoma in situ (DCIS) are likely to go on to develop invasive breast cancer and which women ...

Risk of progression differs in high risk and low risk cases when surgery is omitted Ductal carcinoma in situ (DCIS) is a non-obligate precursor lesion of invasive breast cancer. Since the ...

Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ.

For women with a type of breast cancer called ductal carcinoma in situ, or DCIS, a new test is available to help guide treatment and determine if radiation is the proper course of action.